A carregar...
The emerging role of antibody-drug conjugates in urothelial carcinoma
INTRODUCTION: In December 2019, the US Food and Drug Administration granted accelerated approval to the novel nectin-4-targeting antibody-drug conjugate, enfortumab vedotin, for the treatment of platinum-refractory and immune checkpoint blockade-refractory locally advanced or metastatic urothelial c...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7545404/ https://ncbi.nlm.nih.gov/pubmed/32552213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2020.1782201 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|